Skip to main content

Table 4 CHEERS 2022 checklist quality results

From: Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review

Item

CHEERS Criteria

Authors (Year)

Lim et al. (2018) [30]

Sun et al. (2022) [32]

Wu et al. (2023) [29]

Manchanda et al. (2020) [31]

Simoes Correa-Galendi et al. (2021) [33]

Lourencao et al. (2022) [34]

Title

1

Title

Yes

Partial

Partial

Partial

Partial

Partial

Abstract

2

Abstract

Yes

Partial

Yes

Partial

Yes

Partial

Introduction

3

Background and Objectives

Yes

Yes

Yes

Yes

Yes

Yes

Methods

4

Health economic analysis plan

Yes

Yes

Yes

Yes

Yes

Yes

5

Study population

Yes

Yes

Yes

Yes

Yes

Yes

6

Setting and location

Yes

Yes

Yes

Yes

Yes

Yes

7

Comparators

Yes

Yes

Yes

Yes

Yes

Yes

8

Perspective

Yes

Yes

Partial

Yes

Yes

Yes

9

Time horizon

Partial

Partial

Partial

Yes

Yes

Yes

10

Discount rate

Yes

Yes

Yes

Yes

Yes

Yes

11

Selection of outcomes

Yes

Yes

Yes

Yes

Yes

Yes

12

Measurement of outcomes

Yes

Yes

Yes

Yes

Yes

Yes

13

Valuation of outcomes

Yes

Yes

Yes

Yes

Yes

Partial

14

Measurement and valuation of resources and costs

Yes

Yes

Yes

Yes

Yes

Yes

15

Currency, price date, and conversion

Yes

Yes

Yes

Yes

Yes

Yes

16

Rationale and description of model

Yes

Yes

Yes

Partial

Yes

Partial

17

Analytics and assumptions

Partial

Partial

Yes

Yes

Yes

Yes

18

Characterizing heterogeneity

Yes

Yes

No

Yes

Yes

Yes

19

Characterizing distributional effects

Yes

Yes

Yes

Yes

Yes

Yes

20

Characterizing uncertainty

Partial

Partial

Yes

Partial

Partial

Partial

21

Approach to engagement with patients and others affected by the study

Partial

Partial

Partial

No

No

Partial

Results

22

Study parameters

Yes

Yes

Yes

Yes

Yes

Yes

23

Summary of main results

Yes

Yes

Yes

Yes

Yes

Yes

24

Effect of uncertainty

Partial

Partial

Yes

Partial

Partial

Yes

25

Effect of engagement with patients and others affected by the study

No

No

No

No

No

No

Discussion

26

Study findings, limitations, generalizability, and current knowledge

Yes

Yes

Yes

Yes

Yes

Yes

Other relevant information

27

Source of funding

Yes

Yes

Yes

Yes

Yes

Yes

28

Conflicts of interest

Yes

Yes

Yes

Yes

Yes

Yes

  1. Note Fully Reported: Yes, Partially Reported: Partial, Not Reported: No